Cough Syrup Deaths: SC Dismisses PIL for CBI Probe, Nationwide Reforms
New Delhi, Oct 10: The Supreme Court on Friday dismissed a PIL seeking an inquiry and systemic reforms in drug safety following deaths of children in Madhya Pradesh and Rajasthan, allegedly caused by toxic cough syrups. A bench comprising Chief Justice B.R. Gavai and Justices Ujjal Bhuyan and K. Vinod Chandran rejected the plea filed [] The post Cough Syrup Deaths: SC Dismisses PIL for CBI Probe, Nationwide Reforms appeared first on Northlines .
Cough syrup deaths: SC rejects PIL seeking CBI probe, drug safety review; toll at 21 in MP
The Supreme Court has dismissed a plea for a CBI investigation into the deaths of children in Madhya Pradesh and Rajasthan. These deaths were reportedly caused by a toxic cough syrup. The manufacturer's owner has been arrested. Several states have banned the syrup, and the factory has been sealed.
Cough Syrup Deaths: SC Rejects PIL Seeking CBI Probe, Nationwide Drug Safety Review
NEW DELHI, Oct 10: The Supreme Court on Friday dismissed a PIL seeking an inquiry and systemic reform in drug safety mechanisms in the wake of deaths of children in Madhya Pradesh and Rajasthan allegedly due to consumption of toxic cough syrups. A bench comprising Chief Justice B R Gavai and Justices Ujjal Bhuyan and K Vinod Chandran dismissed the PIL filed by lawyer Vishal Tiwari after Solicitor General Tushar Mehta objected to it. The top law officer said the [] The post Cough Syrup Deaths: SC Rejects PIL Seeking CBI Probe, Nationwide Drug Safety Review appeared first on Daily Excelsior .
Lokayukta officials in Madhya Pradesh uncovered a vast fortune linked to former PWD chief engineer Govind Prasad Mehra. Searches revealed Rs 36 lakh cash, gold worth over Rs 3 crore, silver, and extensive property holdings. A surprising discovery at his farmhouse was 17 tonnes of honey, alongside luxury vehicles and a PVC pipe factory.
SC to hear PIL on child deaths linked to toxic cough syrup
New Delhi: The Supreme Court is slated to hear on Friday a public interest litigation (PIL) seeking a high-level probe into the deaths of children allegedly caused by the consumption of contaminated cough syrup in Madhya Pradesh and Maharashtra. The PIL claimed that at least 14 children have died since early September, with most of Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
Deepika Padukone Wades Into Ongoing Debates on Work-life Balance
Deepika Padukone visited Madhya Pradesh to mark a special milestone 10 years of her foundation, Live Love Laugh, which continues to play a vital role in spreading awareness and support for mental health across India.
Pushed out by tigers, leopards stray into human dwellings in Uttarakhand
DEHRADUN: A growing tiger population in Uttarakhand is creating tension in the forests, not just among humans but also among wildlife. With more tigers staking claim to prime jungle areas, leopards are being forced out of their natural habitats and into nearby human settlements, sowing the seeds of a human-animal conflict. Forest Department sources said the leopards, caught between the dominance of tigers in the jungle and the dangers of human settlements outside, are struggling to survive. The tiger naturally does not allow any other animal to maintain its dominance in the forests, explained Dr. Saket Badola, Director of the Corbett Tiger Reserve, to TNIE. Since the tiger is much stronger, the leopard does not go for conflict. This imbalance is most visible around the Jim Corbett Tiger Reserve, where rising tiger numbers are encroaching on traditional leopard territory. The Terai Western Forest Division alone is home to 56 tigers. As tigers occupy the core forest areas, leopards are increasingly venturing into fringe zones. Unable to find enough wild prey, they are turning to domestic animals, heightening human-wildlife conflict. Last week, late at night, a leopard snatched a pet dog right from outside our house, said Bhuvan Joshi of Devipura. We have informed the Forest Department and requested them to install a cage to capture the animal. Villagers in Devipura, Basai, and Tanda have reported frequent leopard sightings, adding to the tension. For the last few months, Tanda has been experiencing terror of the leopard. Forget the evenings, we dont even let children play outside during the daytime, said Rahul Pandey of Basai Pirumdara. The Forest Department has installed camera traps in sensitive areas to track leopards and prevent incidents. Incidentally, Uttarakhand has achieved significant success in tiger conservation. It ranks third in India for tiger numbers after Madhya Pradesh (785) and Karnataka (563). The rise in tiger populations is creating ripple effects for other carnivores, requiring careful management to maintain the balance between wildlife and human safety.
Coldrif cough syrup banned in Bengal after child deaths linked to it in Madhya Pradesh
The batch linked to the Madhya Pradesh incident has not entered West Bengal, but as a precautionary measure, we have informed all sellers to stop its sale, BCDA secretary Prithwi Basu said.
MP Cops Take Coldrif Manufacturer Into Custody
Ranganathan was later in the evening taken to Madhya Pradesh after securing the transmit permit, though there was a delay in the court since the documents the Madhya Pradesh submitted in the court were in Hindi.
Luxury Cars, Gold And Honey: Recovery From Retired Madhya Pradesh Engineer
Bhopal woke up to a real-life crime thriller on Thursday as the anti-corruption ombudsman Lokayukta raided the residence and properties of retired Public Works Department (PWD) Chief Engineer GP Mehra, uncovering an unbelievable mountain of wealth.
Madhya Pradesh HC directs govt to relocate toxic ash from Union Carbide
BHOPAL: Unsatisfied with steps taken by the state government for containment of the residual ash generated from incineration of toxic waste of Union Carbide factory site, the Madhya Pradesh government has directed the government to relocate the ash to a place which is far away from human habitation, vegetation and water sources. A division bench of the HC, comprising Justices Atul Sreedharan and Pradeep Mittal directed the state government to file a report citing alternate sites for containment of the ash (instead of presently planned containment site which is just 500 meters from human habitation in Dhar district). The HC further asked the government to inform the court, whether a global tender has been floated to get the best technical expertise of companies/agencies, executing a work of this nature and having dealt with similar cases of containment of toxic chemical waste. Importantly, this is the second time in over two months that the MP HC has directed the state government to relocate the 899 tonnes of ash (generated from the 55-day incineration of the 358 tonnes of toxic waste at the treatment-storage-disposal facility in Pithampur-Dhar) to a site without human habitation. Before its Wednesday order, the HC had also issued similar directions on July 31 . Earlier also, this Court had voiced its apprehension of containing the residual waste proximate to human habitation, as the residual waste is still toxic in nature and if not contained properly, and God forbid, if the containment structure itself is breached collapses on account of a natural disaster like an earthquake, then it would be another disaster in the waiting. This Court had directed the state to examine alternate sites for containment of the toxic ash. In this regard, the State may examine the alternate sites given in one of the intervention applications and consider the feasibility of moving the toxic ash to such places which are far away from human habitation, vegetation and water source, so that even in the event of the containment collapsing, its ill effects are nil to minimal. While mentioning about another intervention application filed in the matter, the HC stated in its Wednesday order, The concerned application discloses that the tests that have been conducted on the toxic ash, still reveal the presence of mercury, which is higher than the permissible limits as disclosed in the Madhya Pradesh Pollution Control Boards Report of August 12, 2025. In support of the structure envisaged for the containment of the toxic ash, the state has made an animated video presentation to contend that the containment structure (barely 500 meters from human habitation) is a state-of-the-art structure employing most modern safety measures. However, it doesnt satisfy the court. In times when new roads are washed away in rains and bridges collapse and worse still, when railway overbridges are constructed with a right-angle turn, reducing this state to a laughingstock nationwide, reposing unflinching faith in the engineering prowess of the state may be an invitation to disaster. The anxiety of this court should not be misconstrued as mocking the state but far from it, the caution being exercised by the court is the result of being once bitten, twice shy. The Union Carbide India Limited factory at Bhopal was safe, till disaster struck in December 1984. Thus, when it comes to the issue of containing the toxic ash, perhaps till Kingdom Come, no amount of caution is in excess. The HC will next hear the matter on November 20. Importantly, the entire 358 tonnes of toxic waste lying at the worst industrial tragedy-struck defunct Union Carbide plant in Bhopal was relocate safely after 40 years on the HCs order on January 1-2, 2025 to the TSDF in Pithampur industrial town of western MPs Dhar district. Based on the HCs directions, the waste was incinerated at the same TSDF in 55 days in May-June, consequently generating 899 tonnes ash, which is planned to be safely disposed in secured landfill/containment structure, close to the TSDF where the waste was burnt.
Amid Cough Syrup Deaths, Madhya Pradesh Blames Tamil Nadu, Alleges Negligence
Madhya Pradesh still reeling from the devastating Coldrif cough syrup tragedy which has claimed the lives of 23 children, Chief Minister Dr. Mohan Yadav has directly blamed the Tamil Nadu government.
MP CM Mohan Yadav accuses TN govt of inadequate support over cough syrup poisoning deaths of 23 kids
BHOPAL: As the death toll of children from cough syrup poisoning continued to rise in Madhya Pradesh, the states chief minister Dr Mohan Yadav has accused the Tamil Nadu government of not providing adequate support on the issue. According to official sources, the death toll of children at hospitals in Nagpur and Chhindwara stands presently at 23, including 20 from Chhindwara, one from Pandhurna and two from Betul district. In an associated development, Ranganathan, the 75-year-old owner of the Tamil Nadu based pharmaceutical unit, which made the cough syrup, was arrested by the MP Polices SIT team from Chennai on the intervening night of Wednesday and Thursday and will be brought to Chhindwara soon. The deaths have happened due to manufacturing defects of the concerned cough syrup, which was being made at the factory in TN. So, the timely action and sampling should first have been initiated there. The Congress leaders who are questioning us should better go to Tamil Nadu and question their alliance partners government in that state, as to how the licence of the factory was renewed. How was it operating in a small place, Yadav said after taking stock of the medical treatment of the affected kids in Nagpur in Maharashtra. Amid the possibility of the Leader of Opposition in the Lok Sabha Rahul Gandhi going to Chhindwara on October 12 to meet the families who have lost their children, the MP CM dared the former AICC president to go to Tamil Nadu and question his partys alliance partner DMK's government on the issue. How was the drug licence issued to the unit, how come it was renewed, how was it allowed to function from a small place? Rahul Gandhi should go to TN and ask these questions to the state government there. Weve been affected by the defective cough syrup which was made in TN, why dont the Congress and Rahul Gandhi raise the issue with the Tamil Nadu government, Yadav said. Centre slams TNFDA for delaying Sresan Pharma licence cancellation after Coldrif cough syrup kills 20 children Yadav visited the hospitals in Nagpur where kids from Chhindwara, Betul and Pandhurna districts are under life-saving treatment following acute renal failure caused by poisoning of the Coldrif cough syrup manufactured at Sresan Pharmaceuticals in TNs Kancheepuram district. Weve already acted against our drug controller and inspectors for failing to perform random sampling of the syrups samples. Action has also been initiated against the doctor who particularly prescribed Coldrif cough syrup, which was sold through the medicine store run in his wifes name. Our police have arrested the owner of the drug manufacturing company in TN, were not going to spare anyone in the matter, the MP CM said. Meanwhile, in a briefing about the arrest of Ranganathan from Chennai, the Chhindwara district police superintendent Ajay Pandey said he was running the pharmaceutical unit as a proprietorship entity along with chemical analysts and other team members. As he is a blood pressure and sugar patient, were getting his thorough medical check-up done in TN, after which he will be produced before a local court there for bringing him on transit remand to Chhindwara. Pandey said, As the investigations progress, more accused will be added. They may be doctors who prescribed the same syrup (and it caused damage to childrens health) or vendors and retailers through whose distribution channels the syrup went to the kids. He said, Our 12-member SIT is probing the case and six members of the team are in Chennai currently to bring Ranganathan to Chhindwara. We are still in the initial stages of the probe. Based on the questioning of the pharmaceutical firm owner, it will be established from whom the hazardous chemical was sourced and more accused will be added. There was a strong possibility of Ranganathan fleeing from the country as his cellphones were switched off, but our team finally managed to nab him. The SP-Chhindwara said the autopsy of three kids has already been conducted, but the post mortem reports cannot be made public. We are working on getting more information with the help of the forensic science lab and experts, he added. Meanwhile, sources privy to the ongoing probe revealed that the TN based pharma making unit, which was first registered as a private limited firm in 1990, was later struck off from the Ministry of Corporate Affairs register, yet continued operating under a proprietary structure, raising serious questions about regulatory oversight. Cough syrup deaths linked to lapses at Sresan Pharma; TN begins inspection of 300 drug units
Madhya Pradesh cough syrup death toll touches 22, CM Mohan Yadav says Tamil Nadu not cooperating
Mohan Yadav questioned the licensing process of pharma companies in Tamil Nadu and demanded a regulatory investigation of the firm
MP CM alleges TN govt not cooperating with cough syrup probe
Nagpur/Bhopal: Madhya Pradesh Chief Minister Mohan Yadav on Thursday alleged that the Tamil Nadu government was not cooperating in connection with the probe linked to the death of 22 children from his state due to consumption of a cough syrup manufactured in the southern state. He said his government will not spare anyone playing with Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
MP Chief Minister Yadav on cough syrup deaths: `Govt won`t spare anyone`
Madhya Pradesh CM Mohan Yadav has vowed strict action after 22 children, mostly from Chhindwara, died from consuming toxic Coldrif cough syrup. The syrup was made by a Tamil Nadu-based firm, whose owner, Ranganathan, was arrested. A Special Investigation Team has been formed to probe the tragedy
Tamil Nadu suspends drug inspectors after deadly cough syrup deaths in Madhya Pradesh
Tamil Nadu has suspended two senior drug inspectors following the deaths of over 20 children in Madhya Pradesh due to a contaminated cough syrup. The inspectors are accused of negligence for failing to inspect the manufacturing unit of Sresan Pharmaceuticals, which was found to have severe lapses in production and hygiene.
'Our govt will not spare the accused,' says MP CM Mohan Yadav on arrest of Sresan Pharma Owner
Madhya Pradesh Chief Minister Mohan Yadav has vowed strict action against all accused in the Chhindwara cough syrup deaths. The owner of Tamil Nadu-based Sresan Pharmaceuticals, manufacturer of the implicated Coldrif cough syrup, has been arrested. The state government is actively investigating and ensuring such incidents are prevented in the future.
The inspectors failed to conduct quality checks on drugs manufactured by Sresan Pharmaceuticals, whose Coldrif cough syrup is linked to the deaths of several children in Madhya Pradesh
Madhya Pradesh police arrest Sresan Pharma owner after Coldrif syrup kills over 20 children
Madhya Pradesh: For Young Baiga Painters, Art is Inheritance But Not a Secure Livelihood
In Lorha village, the next generation keeps Baiga painting alive, even as earnings remain meagre and middlemen profit from their work.
SC to hear plea seeking CBI probe, nationwide drug safety overhaul in cough syrup deaths
The Supreme Court agreed to hear on Friday a Public Interest Litigation (PIL) demanding a CBI probe and sweeping reforms in Indias drug safety framework, following the recent deaths of children in Madhya Pradesh and Rajasthan allegedly due to toxic cough syrups . A bench led by Chief Justice B R Gavai, along with Justices Ujjal Bhuyan and K Vinod Chandran, took note of the urgency flagged by petitioner and scheduled the matter for hearing on October 10. Filed by advocate Vishal Tiwari, the plea seeks a court-monitored investigation and the formation of a National Judicial Commission or Expert Committee led by a retired Supreme Court judge to ensure accountability. The petition calls for all related FIRs and state-level probes to be handed over to the CBI, citing fragmented investigations and regulatory lapses that have allowed unsafe medicines to reach consumers. Amid growing concern over the deaths, the PIL urges the Centre to constitute a national-level body to probe systemic regulatory failures and to direct mandatory toxicological testing of all suspect drugs through NABL-accredited labs before further sale or export. The case follows alarming reports of multiple child deaths allegedly linked to a specific brand of cough syrup in Madhya Pradesh and Rajasthan. (With inputs from PTI) Owner of TN-based Sresan Pharma arrested in Chennai over cough syrup deaths
Four killed, three injured in car-van collision in Madhya Pradesh's Indore
MHOW: Four persons were killed and three others injured when a car and a van collided in Madhya Pradesh's Indore district, police said on Thursday. The van caught fire after the accident which occurred late Wednesday night near Awlay village on the Agra-Mumbai National Highway in Mhow tehsil, about 30 km from the district headquarters, they said. The car heading towards Manpu in Mhow collided with the van coming from the opposite direction at high speed at around 11.15 pm. The van caught fire and it intensified due to paint cans stored in its rear portion, Badgonda police station house officer Prakash Waskale told PTI . A fire brigade team later reached the spot and brought the blaze under control. Two persons travelling in the van were charred to death and two car occupants died on the spot, the official said. Three others were injured in the incident, the official said. Out of the four deceased, three have been identified as Palak (34), a resident of Manpur in Mhow, Kamlesh (20) and Ravindra, both from neighbouring Dhar, the official said. Police registered a case and were investigating the incident.
Cough syrup deaths: SC agrees to hear PIL seeking CBI Probe, nationwide drug safety review
The Supreme Court will hear a PIL on Friday concerning systemic reforms in drug safety following child deaths in Madhya Pradesh and Rajasthan allegedly due to toxic cough syrups. The plea seeks a court-monitored probe, transfer of FIRs to CBI, and identification of regulatory failures to prevent hazardous formulations from reaching the market.
Cough syrup-linked deaths: Toll rises to 22 as two more children succumb
Two more children in Madhya Pradesh have died from kidney infections linked to a contaminated cough syrup, raising the death toll to 22. The victims, aged 4 and 5, were from Chhindwara. Police have arrested the owner of the Tamil Nadu-based manufacturer of the 'toxic' Coldrif cough syrup.
Cough syrup case: Death toll rises to 22 as two more children die in MP
The death toll in the toxic cough syrup tragedy in Madhya Pradesh rose to 22 after two more children from Chhindwara district died due to suspected kidney failure linked to the consumption of Coldrif cough syrup. Officials confirmed that Vishal (5) and Mayank Suryavanshi (4), both from Parasia town, died during treatment at a Nagpur hospital on Wednesday. Several other children from the district remain hospitalized. Authorities believe the deaths were caused by kidney damage resulting from toxic contamination in the Coldrif syrup , manufactured by Tamil Nadu-based Sresan Pharma. A Special Investigation Team (SIT) has arrested Ranganathan Govindan , the owner of Sresan Pharma, from Chennai. The companys manufacturing unit has been sealed, and Govindan will be brought to Madhya Pradesh after securing a transit remand from a Chennai court.
Madhya Pradesh Minister blames Tamil Nadu for cough syrup deaths
Meanwhile, Congress accuses Madhya Pradesh government of complete failure in matter
Was cough syrup linked to child deaths exported to other countries: WHO to Indian authorities
NEW DELHI : The World Health Organisation has sought to know from Indian authorities whether the cough syrup linked to child deaths in the country was exported to other nations, sources said on Thursday. They said the global health agency will take a call on issuing a 'Global Medical Products Alert' on the cough syrup, Coldrif, after receiving an official confirmation from authorities here. The agency issues such alerts for substandard and contaminated medicines. Five children from Madhya Pradesh are in a critical condition, while 20 have died due to kidney infections caused by the consumption of the contaminated cough syrup, containing Diethylene Glycol (DEG) and Ethylene Glycol (EG). Besides, at least three children have allegedly died in Rajasthan after consuming cough syrup in different districts of the state. The World Health Organisation (WHO) on Wednesday has asked for a clarification on whether the cough syrup linked to children deaths in the country was exported to other countries as part of the routine process, the sources said. The Drugs Controller General of India (DCGI) on Wednesday had urged all state and UT drug controllers to ensure testing of raw materials and finished formulations of pharmaceutical products before releasing in them in the market in the wake of children deaths allegedly due to consumption of contaminated cough syrup in Madhya Pradesh. In an advisory, the DCGI said during recent inspections at manufacturing facilities and in the investigations of the drugs declared as 'Not of Standard Quality', it was found that several manufacturers are not testing each batch of excipients and active ingredients for compliance with prescribed standards before use. There have been recent reports of child deaths in Chhindwara in Madhya Pradesh, allegedly linked to contaminated cough syrups and concerns related to quality of these cough syrups, the advisory stated. During the inspections carried out at the manufacturing facilities and in the investigations of the drugs declared as Not of Standard Quality, it was observed in the reports that the manufacturers are not carrying out testing of each batch of the excipients/inactive and active pharmaceutical ingredients for verification of compliance with the prescribed standards before using them in the manufacture of formulations and also in the finished products, the advisory dated October 7 said. All State/UT drug controllers are requested to take measures to ensure testing before the manufacture and release of the batch to the market by way of monitoring during inspections, sensitising the manufacturers through circulars, etc. Further, it shall also be ensured that the manufacturers have robust vendor qualification system in place and use raw materials including excipients from reliable approved vendors only, the advisory said. The Centre in 2023 had ordered pharma companies to mention warnings on the label and the package insert stating the fixed-dose combination (FDC) of chlorpheniramine maleate IP 2mg and phenylephrine HCl IP 5mg drop/ml should not be used in children below four years of age. Centre slams TNFDA for delaying Sresan Pharma licence cancellation after Coldrif cough syrup kills 20 children
WHO Flags Regulatory Gap, Export Risks After Cough Syrup Tragedy
Amid the nationwide outrage over children's deaths caused by adulterated cough syrups in Madhya Pradesh and Rajasthan, the World Health Organization (WHO) has expressed concern over the egulatory gap in screening
Explained: The Toxic Truth Behind India's Cough Syrup Deaths
In Madhya Pradesh, the death toll of children who died after consuming contaminated cough syrup has climbed to 20.
Owner of TN-based Sresan Pharma arrested in Chennai over cough syrup deaths
A Special Investigation Team (SIT) from Madhya Pradesh, with the assistance of Chennai City Police, arrested Ranganathan (75), the proprietor of Tamil Nadu-based Sresan Pharma, in connection with the manufacture of spurious cough syrup that has been linked to multiple child deaths across several states. Ranganathan was picked up from his residence in Kodambakkam by the SIT, accompanied by personnel from the Ashok Nagar police station under whose jurisdiction the area falls. He was subsequently taken to the Sunguvarchatram police station in Kancheepuram district for preliminary questioning. The arrest pertains to the production of Coldrif cough syrup, which was found to contain diethylene glycol (DEG), a toxic chemical compound that has been implicated in the deaths of children who consumed the syrup. The Madhya Pradesh police are investigating the case, and a transit warrant is being processed to facilitate the transfer of the accused to MP for further custodial interrogation. Soon after the arrest, the SIT along with local authorities carried out a detailed inspection of the manufacturing facility of Sresan Pharma, located in a rented 4,500 sq ft premises in Sunguvarchatram. The unit has since been sealed by officials of the Tamil Nadu Drugs Control Department, who found several violations of manufacturing protocols. According to official sources, the pharma unit allegedly failed to procure pharma-grade propylene glycol, a key ingredient in cough syrups, and instead sourced substandard material containing DEG as an impurity. Samples seized from the premises reportedly tested positive for the toxic substance. Sources indicated that following completion of legal formalities, the SIT from Madhya Pradesh is expected to take custody of Ranganathan to continue the investigation. Centre slams TNFDA for delaying Sresan Pharma licence cancellation after Coldrif cough syrup kills 20 children
Owner of Coldrif Cough Syrup Manufacturer Arrested After 21 Child Deaths in MP and Rajasthan
Sresan Pharmaceuticals owner Ranganathan was arrested in Chennai after 21 children died in Madhya Pradesh and Rajasthan. Tests revealed Coldrif Cough Syrup contained 48.6% toxic diethylene glycol.
The Dramatic Operation Behind Pharma Owner's Arrest In Cough Syrup Tragedy
The pharmaceutical company owner, the key accused in the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh, was arrested by the state police after a dramatic midnight operation.
MP cough syrup deaths: Maharashtra FDA orders inspection of liquid oral formulations
Following the deaths of 20 children in Madhya Pradesh due to a contaminated cough syrup, the Maharashtra FDA has initiated a special drive. This includes inspecting manufacturers and testing liquid oral formulations from hospitals and distributors to ensure quality and prevent similar incidents.
NEW DELHI/CHENNAI/BHOPAL: The Centre has pointed fingers at the Tamil Nadu Food and Drug Administration (TNFDA) for not yet cancelling the licence of Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup, linked to the deaths of at least 20 children in Madhya Pradesh. According to sources in the Union health ministry, the TNFDA was directed by the Central Drugs Standard Control Organisation (CDSCO) to cancel the licence of the pharma company based in Kanchipuram, Tamil Nadu, on October 4. The TNFDA is yet to cancel the license of the company despite CDSCO recommendations, sources told TNIE . However, Tamil Nadu State Drug Control Department on Wednesday initiated criminal proceedings against G Ranganathan, proprietor cum manufacturing chemist of Sresan Pharmaceuticals. A special investigation team (SIT) from Madhya Pradesh arrived in Chennai and held discussions with the Tamil Nadu State Drug Controller. Ranganathan, who has been in the pharma manufacturing field for over 40 years, is absconding. The SIT lodged a police complaint against Ranganathan, sources said. Since Sresan is already shut, the departments show cause notice was pasted on the doors of the unit in Kanchipuram and on Ranganathans residence in Chennai. The notice gives Ranganathan time till October 12 to submit his response. Possibly on October 13, formal orders to cancel Sresans licence would be issued. Its current licence is valid till December this year, officials said. Company owner absconding with wife: MP police Convictions under the Drugs and Cosmetics Act 1940 stipulate a minimum jail term of 10 years, which may extend up to life imprisonment and with a fine of not less than Rs 10 lakh, said S Gurubharathi, Deputy Director of Drugs Control and Licensing cum Controlling Authority, TN. Officials said the show cause blames the manufacturer of misbranding. For, the label of the container ought to have carried a warning that fixed dose combination shall not be used in children below four years of age. This is mandatory as per gazette notification dated 15 April 2025 of the Union health ministry and circular dated 18 December 2023 of the Central Drugs Standard Control Organisation. Failure to do so violates Section 18(a)(i) read with Section 17 (b) of the Drugs and Cosmetics Act 1940. Meanwhile, Congress leader Rahul Gandhi is likely to travel to Chhindwara district on October 11 or 12, where he will meet the bereaved families. Till now 20 children from Chhindwara, Pandhurna and Betul have died due to the unfortunate and painful incident. Five children are being treated in government and private hospitals in Nagpur and all efforts are underway to save their lives, MP deputy CM and health minister Rajendra Shukla said. Our SIT in coordination with the local police in TN, has conducted investigations and raids at multiple locations, but the companys owner has gone into hiding along with his wife. Were also investigating the role of the companys directors and other officials, who might be directly or indirectly associated with the adulteration of the syrup, a senior Chhindwara police officer told this newspaper. Cough syrup unit was to be shut after December Ranganathan, 75, has been running the Kanchi unit at its rented location (pic) since 2013. The owner of the building said Ranganathan had not paid rent for the last six months. Ranganathan was planning to stop the production of cough syrups after December because of advanced age, sources said Cough syrup deaths linked to lapses at Sresan Pharma; TN begins inspection of 300 drug units
Madhya Pradesh police arrested Sresan Pharmaceuticals owner G Ranganathan, 73, in Chennai after his cough syrup, Coldrif, was linked to 21 child deaths due to toxic chemicals. The company, despite operating with numerous violations for years, is now under national scrutiny, with its manufacturing unit sealed.
Cough syrup row: Owner of Sresan Pharmaceuticals, maker of Coldrif syrup, arrested over child deaths
S Ranganathan, owner of Sresan Pharmaceuticals, maker of Coldrif cough syrup, was detained in connection with the deaths of several children in Madhya Pradesh and Rajasthan.
Death penalty: SC rejects Centre plea for framing victim-centric guidelines
NEW DELHI: The Supreme Court on Wednesday rejected the Centres application for laying down victim- and society-centric guidelines in heinous offence cases where the death penalty is awarded. We do not find any merit in this MA (Miscellaneous Application) filed by the Centre, said the three-judge bench of Justices Vikram Nath, Sandeep Mehta, and N V Anjaria. The Centre filed the application in January 2020, stating that existing guidelines in death penalty cases primarily focus on the accused and convicts. The Centre requested the court consider introducing provisions that also account for the interests of victims and society, especially in cases that shake the collective conscience of the court. The application also sought modifications to the directions of the Supreme Court in the landmark case of Shatrughan Chauhan vs. Union of India (2014), which laid down procedural guidelines for dealing with mercy petitions and the execution of death row convicts. On January 31, 2020, the top court agreed to examine the Centres application and sought responses from various stakeholders, but clarified that the conviction and sentence in the Shatrughan Chauhan case would remain undisturbed. The Centre submitted in its Miscellaneous Application that there was no time limit for availing legal and constitutional remedies, leading to delays in the execution of death sentences. It urged the Court to establish guidelines that balance the interests of victims and society, alongside the existing protections for convicts. The Centre also referred to delays in the execution of the four individuals convicted in the 2012 Nirbhaya case, which extended over several months due to the sequential filing of review, curative, and mercy petitions. After reviewing the case, the top court rejected the Centres application. Also in top court MP, CBI told to explain delay in cops arrest The Supreme Court on Wednesday sought an explanation from the CBI and the Madhya Pradesh government over delay in arresting two policemen involved in the alleged custodial death of a 24-year-old man. A bench of Justices BV Nagarathna and R Mahadevan passed the order. Tech issues shouldnt deny compensations Observing that a hyper technical approach should be avoided, the Supreme Court on Wednesday said mere technical irregularities or lapses in procedure should not deny a legitimate claim of compensation in railway accidents. The court made the observation while setting aside an order of the MP High Court.
Cough syrup tragedy: Police arrest Sresan Pharma owner S. Ranganathan
Madhya Pradesh Police have arrested S. Ranganathan, owner of Sresan Pharma, in connection with the toxic cough syrup Coldrif, which allegedly caused the deaths of 20 children. Preliminary reports indicate the syrup contained toxic substances leading to severe kidney damage. The state government has increased health safety measures and is conducting public awareness drives.
Cough syrup deaths: IMA seeks withdrawal of case against RMP
New Delhi: In view of pediatricians arrest following deaths of children due to the consumption of a contaminated cough syrup in Madhya Pradesh, the Indian Medical Association (IMA) on Wednesday sought Union Health Minister JP Naddas intervention into the matter and immediate withdrawal of the case against the bona fide medical practitioner. Condemning the action Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
Children's deaths in MP due to renal failure were initially reported in September, with authorities taking action after Nagpur hospitals alerted them. Biopsy reports confirmed acute tubular injury, leading to the identification of substandard cough syrups, including Coldrif, containing toxic diethylene glycol, prompting a state-wide ban.
Tragedy strikes as cough syrup deaths climb to 21 across Madhya Pradesh, with new fatalities in Betul and Pandhurna. Chief Minister Mohan Yadav admitted to systemic lapses, vowing to improve coordination. The poisonous diethylene glycol in Coldrif syrup is blamed for renal failure. Meanwhile, a one-year-old boy recovered, offering a glimmer of hope amidst the ongoing investigation into the manufacturer.
Contaminated cough syrup, containing lethal diethylene glycol, caused child deaths in Rajasthan and Madhya Pradesh, exposing critical flaws in India's pharmaceutical quality control. Multiple safeguards failed, from manufacturing to distribution, highlighting the urgent need for robust regulatory reforms and proactive prevention to ensure drug safety.
Watch: Cough syrup deaths in Madhya Pradesh: Families mourn victims, demand justice
In Madhya Pradeshs Chhindwara district, grief runs deep. Families who lost their children after consuming a cough syrup named Coldrif are still waiting, for justice, for answers, and for accountability.
Criminal action will be taken against manufacturer for supplying contaminated syrup: Health Minister
Ma. Subramanian says the Drug Control Department of Madhya Pradesh sent a letter to Tamil Nadu on October 1 following the death of children due to two syrups suspected to have been contaminated. Since the manufacturer of one of the syrups was from Tamil Nadu, the government banned its sale across the State
Exclusive: How Madhya Pradesh's Drug System Failed To Stop A 'Killer' Syrup
In Madhya Pradesh, 20 children are dead and seven more are battling for life after consuming a toxic cough syrup that should never have reached them.
Madhya Pradesh SIT conducts probe at factory, registered address of cough syrup maker in Tamil Nadu
The Chennai-based pharmaceutical company has been supplying the cough syrup 'Coldrif' to Puducherry, Madhya Pradesh and Rajasthan and also some others, sources said
Drug row: Pharma firm to face criminal action, says TN minister
Tamil Nadu's health minister announced criminal action against a drug manufacturer whose cough syrup, Coldrif, was found to contain diethylene glycol. This substance was linked to the deaths of 20 children in Madhya Pradesh due to kidney failure.
'Doctor Scapegoat To Quell Outrage': Medical Body On Cough Syrup Deaths
A doctor is being made the scapegoat for the cough syrup tragedy in Madhya Pradesh, and those approving such drugs must face action, an all-India organisation of doctors has said.
A seven-member Special Investigation Team (SIT) from Madhya Pradesh, led by an Assistant Commissioner of Police, conducted a probe at the factory of a drug manufacturer near Chennai on Wednesday to investigate the deaths of 20 children in Madhya Pradesh allegedly caused by contaminated cough syrup. The SIT later visited the companys registered office in Chennai to gather documents and CCTV footage. Officials said the factory owner had left the premises three days earlier. The Tamil Nadu police assisted the SIT during the inspections. The pharmaceutical company, based in Chennai, had supplied the cough syrup Coldrif to markets in Puducherry, Madhya Pradesh, Rajasthan and other states. Earlier, the Tamil Nadu government had sealed the pharmaceutical factory in Kancheepuram district on Tuesday evening. Madhya Pradesh Deputy Chief Minister Rajendra Shukla said on October 7 that 20 children had died from kidney failure after consuming the syrup. Tests conducted by the Tamil Nadu Food Safety and Drug Administration found the samples from the factory to be adulterated, following which production was ordered to stop immediately. Five children remain critical after contaminated cough syrup claims 20 lives The state government also banned the sale of Coldrif from October 1 and directed that all stocks be removed from the market. The company has not yet issued any statement. 'Public alert - stop use notice' against two cough syrups in Telangana Meanwhile, the Telangana Drugs Control Administration issued a public alert stop use notice for two other syrups -- Relife and Respifresh TR -- manufactured by Gujarat-based firms, after laboratory tests in Madhya Pradesh detected the toxic chemical Diethylene Glycol (DEG). Authorities urged the public to stop using these products and report them to local drug control offices. The incident came to light after six children, aged between one and seven, from different parts of the Parasia area (also known as Koylanchal for its coal mining activity), died from kidney-related complications after consuming adulterated cough syrup. The children initially suffered from cold and mild fever. Local doctors prescribed routine medications, including cough syrups. After taking the medicines, the children initially appeared to recover, but within days their symptoms returned, accompanied by a sharp decline in urine output. Dr Praveen Soni , who prescribed the syrup to kids in Madhya Pradesh, has been arrested on charges of negligence. However, the Indian Medical Association (IMA) defended Soni , arguing that systemic lapses by the pharmaceutical company and regulatory authorities also contributed to the tragedy. The IMA has demanded strict action against those responsible for the deaths linked to contaminated cough syrup, compensation for affected families, and support for the doctor. It criticised the poor drug regulations and mishandling of the case. Tests suggest the syrup contained toxic chemicals and was wrongly sold for children under four. The Madhya Pradesh government has suspended two drug inspectors and a deputy director, and transferred the state drug controller. The Union Health Ministry found one of ten syrup samples failed quality tests and has launched inspections in six states. Several states, including Madhya Pradesh, Rajasthan, Tamil Nadu, Maharashtra and Uttar Pradesh, have banned Coldrif syrup and seized contaminated batches. The Punjab and Himachal Pradesh governments have also banned the sale, distribution and use of Coldrif cough syrup. Rajasthan and Uttar Pradesh have started safety drives and surveys, while opposition parties have demanded accountability and a judicial probe into the regulatory lapses behind the tragedy. A Public Interest Litigation (PIL) has been filed in the Supreme Court demanding a CBI probe and sweeping reforms in Indias drug safety framework following the incident. (With inputs from PTI)
Tamil Nadu-based Sresan Pharmaceuticals, manufacturer of the toxic Coldrif cough syrup, operated with unhygienic conditions and purchased non-pharmaceutical grade propylene glycol without invoices. State drug inspectors found multiple violations, including improper storage and faulty equipment, leading to the Kancheepuram unit being sealed. The company's proprietor faces a case filed by Madhya Pradesh.
Ayurvedic cough syrups, home remedies are safe and effective for children: Expert
New Delhi, Oct 8: Amid concerns regarding the quality of cough syrups being administered to children, experts say Ayurvedic remedies are a completely safe and effective alternative. Dr R P Parasher, the national president of All India Doctors Association of Indian System, on Tuesday said that Ayurvedic cough syrups, herbs and home remedies can be given to children over two years of age without fear. The remarks amid the recent deaths of several children in Madhya Pradesh, allegedly due to [] The post Ayurvedic cough syrups, home remedies are safe and effective for children: Expert appeared first on Daily Excelsior .
Five children remain critical after contaminated cough syrup claims 20 lives
At least 20 children have died in Madhya Pradesh after consuming the toxic Coldrif cough syrup, while five more children remain in critical condition undergoing treatment in neighbouring Nagpur, officials confirmed. The development has prompted heightened scrutiny of the manufacturer and regulatory processes across multiple states. Most victims were from Chhindwara district, with two from Betul and one from Pandhurna. The children reportedly developed kidney failure after consuming the syrup manufactured by Sresan Pharmaceuticals, a company based in Kancheepuram, Tamil Nadu. Deputy Chief Minister and Health Minister Rajendra Shukla said that of the five critically ill children in Nagpur, two are admitted at AIIMS, two in a government hospital, and one in a private hospital, adding that everyone is trying their best to save their lives. Shukla met with families of the affected children during his visit to Nagpur. A police team from Chhindwara has reached Kancheepuram to arrest the owner of the company that produced the contaminated syrup. The Madhya Pradesh Police have also formed a Special Investigation Team (SIT) and registered a case against the manufacturer. Dr. Praveen Soni , who prescribed the syrup, has been arrested on charges of negligence. However, Indian Medical Association president Dr. Dilip Bhanushali defended Soni , arguing that systemic lapses by the pharmaceutical company and regulatory authorities also contributed to the tragedy. Demanding immediate action on the actual culprits and adequate compensation for the affected families and the doctor who is a victim of defamation, the IMA on Monday had said they are concerned with the incompetence and inadequacy of the drug regulatory system in the country and mishandling of this unfortunate incident. Preliminary investigations suggest that the syrup may have contained toxic chemicals, and authorities noted that the product should not have been prescribed to children under four years, yet was being sold freely. In response, the Madhya Pradesh government has taken administrative action, suspending two drug inspectors and a deputy director of the Food & Drug Administration, and transferring Drug Controller Dinesh Maurya. The Union Health Ministry said 19 samples of the syrup have been collected for testing. Of the 10 reports received so far, one failed quality standards, while the remaining met regulatory norms. The ministry has also initiated risk-based inspections of pharmaceutical units in six states to identify potential lapses in production and testing processes. The crisis has widened beyond Madhya Pradesh, with similar cases reported in Rajasthan. Several states, including Madhya Pradesh, Rajasthan, Tamil Nadu, Maharashtra, and Uttar Pradesh, have banned Coldrif syrup, seized contaminated batches, and launched investigations into its distribution. The Maharashtra FDA has also restricted the sale and use of Batch No. SR-13, which was found contaminated. States have begun implementing stricter safety measures. Rajasthan has started door-to-door surveys, awareness campaigns, and technical committees to investigate child health issues, while also mandating special warning labels on syrups harmful to children and pregnant women. Uttar Pradesh has seized contaminated batches and other products from the same manufacturer following nationwide alerts. Families of the victims remain devastated. Opposition leaders have demanded accountability and a judicial inquiry into the tragedy. Congress had said that a government probe alone cannot uncover the full truth and called for an independent investigation into systemic failures in drug regulation that may have contributed to the deaths. Cough-syrup deaths: Congress demands judicial probe, compensation for deceased's families
Coldrif row: After 20 children die in Madhya Prdesh, WHO seeks clarification from India over...
The World Health Organisation (WHO) has sought clarification from the government on whether the Coldrif cough syrup, connected to the death of 20 children in Madhya Pradesh, was exported to other countries, as per a report by Reuters.
Death toll due to Coldrif cough syrup rises to 20 in Madhya Pradesh
The Deputy CM further said that he requested the doctors not go on a strike, keep continuing their work and to follow the advisory of the Indian government and ICMR (Indian Council of Medical Research) not to prescribe any cough syrup to children less than four years old
Arunachal govt bans sale of Coldrif cough syrup
ITANAGAR: The Arunachal Pradesh government has banned the sale and use of Coldrif cough syrup in the wake of the death of 14 children in Madhya Pradesh, linked to consumption of the medicine, an official said on Wednesday. The Arunachal Pradesh Drugs Control has issued an advisory prohibiting the sale, distribution, and stock of Coldrif cough syrup, manufactured by Sresan Pharmaceutical, the official said. The advisory has been issued following reports linking the cough syrup to child deaths in other states, including Madhya Pradesh and Rajasthan, and a general advisory for rational use of the cough syrup in the paediatric population by the Director General of Health Services, Government of India, Arunachal Pradesh Drugs Controller Dr Komling Perme said. Cough syrup deaths: Punjab and HP governments ban Coldrif The Health Department has directed stockists/retailers that the product should not be purchased, sold, or stocked for public consumption. If the stockists/retailers are in possession of the product, they must report it to the local drugs control authority immediately, the official said. The advisory also directed physicians in both government and private hospitals to be on vigil while prescribing cough syrup to children. Meanwhile, the department has advised the general public to avoid consumption of the cough syrup.
Telangana DCA issues alert on adulterated cough syrups
Hyderabad: The Drugs Control Administration, Telangana, has received an alert from the Drug Testing Laboratory, Government of Madhya Pradesh, Bhopal, regarding laboratory reports that have declared the following two cough syrups as adulterated with Diethylene Glycol (DEG), a highly toxic substance: Relife Cough Syrup (Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate & Menthol Syrup) Batch No.: LSL25160 Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
Custodial death: SC seeks explanation from CBI, MP Govt over delay in arresting policemen
NEW DELHI, Oct 8: The Supreme Court on Wednesday sought an explanation from the CBI and the Madhya Pradesh Government over delay in arresting two policemen involved in the alleged custodial death of a 24-year-old man. A bench of Justices BV Nagarathna and R Mahadevan passed the order after the CBI informed it that both absconding officers have been arrested. The top court noted that the officers were not arrested despite the May 15 order and the state Government [] The post Custodial death: SC seeks explanation from CBI, MP Govt over delay in arresting policemen appeared first on Daily Excelsior .
SC raps CBI and MP govt over delay in arrest of policemen in custodial death case
NEW DELHI: The Supreme Court on Wednesday sought an explanation from the Central Bureau of Investigation (CBI) and the Madhya Pradesh government over the delay in arresting two policemen involved in the alleged custodial death of a 24-year-old man. A bench comprising Justices B.V. Nagarathna and R. Mahadevan passed the order after the CBI informed the court that both absconding officers had finally been arrested. The apex court noted that the officers had not been apprehended despite its order dated 15 May, and remarked that the state government had only swung into action after the filing of the contempt petition and the courts subsequent observations. What happened all these days? Why couldnt you trace them? We had to almost frame contempt charges for you to act. This is not how a Supreme Court order should be applied. There was a three-judge bench order for arrest, the bench stated. Expressing concern over the conduct of the accused officers, the court asked, What departmental action has been taken against the two officers? They even filed for anticipatory bail despite this courts order that they should be arrested? During the hearing, Additional Solicitor General Raja Thakare, representing the CBI, informed the court that the agency had complied with its order and both officers had now been arrested. Uttam Singh was arrested in Indore on 27 September, and Sanjeev Singh was taken into custody in Shivpuri on 5 October. Both are currently lodged in Indore jail, Thakare said. The bench also directed the Madhya Pradesh government to provide details of the departmental proceedings initiated against the two officers. The matter has been posted for further hearing on 6 November. The court was hearing a contempt plea filed by the mother of the deceased, alleging non-compliance with the Supreme Courts 15 May directive. On that date, the apex court had strongly criticised the Madhya Pradesh government for inaction against the policemen allegedly involved in the custodial death and transferred the investigation to the CBI. The investigating officer, who took over the case on 30 June, had arrested another police official on 2 July based on an eyewitness account revealing custodial torture. On 25 September, the bench had sharply criticised both the Madhya Pradesh government and the CBI for failing to suspend the absconding officers and warned of initiating contempt proceedings. It noted that the officers had been absconding since April yet remained unsuspended. The CBI later informed the court that the suspensions were carried out on 1 October. The bench had earlier reprimanded the agency for its failure to arrest the absconding officers promptly.
Arunachal Pradesh bans sale of Coldrif cough syrup
Arunachal Pradesh has banned Coldrif cough syrup. This action follows the deaths of 14 children in Madhya Pradesh linked to the medicine. The state's Drugs Control has prohibited its sale, distribution, and stocking. Doctors are urged to be cautious when prescribing cough syrups to children. The public is advised to avoid this specific syrup.
From addiction to kidney failure: what parents should know about cough syrup risks
Tragedy strikes Madhya Pradesh as contaminated cough syrup claims 20 young lives. Five more children battle kidney failure after consuming Coldrif syrup. The dangerous chemical diethylene glycol was found in the medicine. Health authorities have issued advisories for children under two. This incident highlights serious safety concerns in pharmaceutical manufacturing and drug distribution.
IAS officer Sanskriti Jain received a grand farewell from her colleagues in Seoni district, Madhya Pradesh, as she concluded her tenure as Collector. Carried on a golden palanquin with her daughters, Jain was honored for her service before moving to Bhopal as Municipal Commissioner and Metro Rail Head.
PIL filed in Supreme Court seeks inquiry into toxic cough syrup deaths of 14
A PIL has been filed in the Supreme Court seeking a probe into the deaths of 14 children in Madhya Pradesh and Rajasthan due to toxic cough syrups. The plea requests a court-monitored inquiry, CBI investigation, and constitution of a national expert body to identify regulatory failures
CBI fails to trace accused in 1992 bank fraud case
BENGALURU: In an over three-decade-old case of public servants conniving with private persons to dupe Bank of India of Rs 45 lakh by releasing cash credit facility in the name of three non-existing firms owned by private persons, the CBI has failed to trace an accused and filed an application to withdraw prosecution of Hemanth Phalke, accused No.7, absconding since the case was filed in 1992. Manjunath Sangreshi, Principal Special Judge for CBI Cases, Bengaluru City, on October 6, allowed the application, noting that he is satisfied with the grounds made out by the public prosecutor. The CBI stated that the Centre has accorded it permission to withdraw the prosecution against the accused under Sec 321 of CrPC. The case was registered against KA Hegde, BK Nair, Manjunath Hegde and others. Phalke, was absconding since the time of investigation, and a split-up charge sheet was filed against him in 1996. The CBI stated before the special court that continued efforts to apprehend Phalke remained unsuccessful. Even non-bailable warrants were not executed. The proclamation was also not executed against him, as nothing in his name or belonging to him was found. Therefore, the special court transferred this case to the Long Pending Register (LPR). It was also stated by the CBI that the firm Nandi Trading Company, of which Phalke was shown to be a partner, was found to be bogus, and all its details were found to be fake. Phalke was last known to have stayed in Vasanthnagar, but had left without leaving any trace in 2006. The CBI has stated that the verifications were made with the office of Registrars in Karnataka, Madhya Pradesh and Maharashtra for ascertaining the details of Phalke, in case he indulged in any property transactions; but it did not yield any fruit. In March 2025, the CBI, Bengaluru, constituted a team headed by a DySP to trace the accused, but to no avail. It is stated that searches through Open Source Intelligence and National Intelligence Data Grid with regards to databases of Bureau of Immigration, CBDT, Central of Board of Indirect Taxes and Customs, Financial Intelligence Unit, ministries of Civil Aviation, External Affairs, Railways, Road Transport and Highways, and NCRB, NHAI, National Population Register were made on the basis of name and parentage of Phalke but no data could be found. Further, it is stated in the application that the charge sheet was filed on March 31, 1995, over 30 years ago. Every effort has been made to trace him for this lengthy period, given the lack of results. The remaining accused of the instant case have already been acquitted by the court vide order dated September 27, 2024.
CCEA nod to 4 multi-tracking railway projects
NEW DELHI: The Cabinet Committee on Economic Affairs (CCEA), chaired by Prime Minister Narendra Modi on Tuesday approved four major railway multi-tracking projects worth Rs 24,634 crore, spanning nearly 900 km across Maharashtra, Madhya Pradesh, Gujarat, and Chhattisgarh.The projects are expected to be completed by 2030-31 and are designed to ease congestion, boost freight capacity, and enhance connectivity across 18 districts in these states. The decision is seen as major infrastructure push under the PM Gati Shakti National Master Plan, aimed at integrating rail development with multi-modal connectivity and improving logistical efficiency. The government expects the additional rail capacity to bring wide-ranging economic and environmental benefits. Briefing reporters after the cabinet meeting, Railway Minister Ashwini Vaishnaw said that the new projects would significantly enhance Indian Railways operational efficiency and reliability. The increased line capacity will significantly improve mobility, resulting in improved operational efficiency and service reliability for Indian Railways, he said. The four projects include construction of third and fourth rail lines between Wardha and Bhusawal (314 route km) in Maharashtra, fourth line between Gondia and Dongargarh (84 km), cutting across Maharashtra and Chhattisgarh, two lines between Vadodara and Ratlam (259 km), spanning Gujarat and Madhya Pradesh and one between Itarsi, Bhopal, and Bina (237 km) in Madhya Pradesh. Together, the projects will expand the Indian Railways network by approximately 894 route kilometres and are expected to ease movement along high-density corridors. The rail corridors covered are crucial for both passenger and freight movement and will reduce delays caused by capacity constraints. The Railway Minister said that the four projects will improve connectivity to 3,633 villages with a total population of about 85.84 lakh, including two Aspirational DistrictsVidisha in Madhya Pradesh and Rajnandgaon in Chhattisgarh. These infrastructure upgrades are aligned with the Prime Ministers vision of a self-reliant India (Atmanirbhar Bharat) and are expected to create significantemployment and self-employment opportunities in the region, Vaishnaw added. The projects will also facilitate access to key tourism and heritage sites such as Sanchi, Satpura Tiger Reserve, Bhimbetka Rock Shelters, Hazara Falls, and Navegaon National Parkall important destinations that currently face logistical bottlenecks. The newly sanctioned lines are projected to handle additional freight traffic of 78 million tonnes per annum (MTPA), including key commodities like coal, cement, fly ash, steel, food grains, and containers. Vaishnaw also stressed the green benefits of railway expansion over road transport. The projects are expected to cut Indias oil imports by 28 crore litres and reduce carbon dioxide emissions by 139 crore kilogramsequivalent to planting around six crore trees. The capacity augmentation has been formulated under the PM Gati Shakti framework, which promotes integrated planning across ministries.
A 14-year unchecked operation of Sresan Pharmaceutical in Tamil Nadu, manufacturing toxic Coldrif cough syrup in unhygienic conditions, led to the death of 17 children in Madhya Pradesh. Fatalities prompted an inspection, revealing critical violations and the presence of diethylene glycol in the syrup.
Centre okays Rs 707 cr relief for Assam, Gujarat
NEW DELHI: A high-level committee of the Ministry of Home Affairs, headed by Home Minister Amit Shah on Tuesday approved additional central assistance of over Rs 707 crore for Assam and Gujarat, which were severely affected by floods and landslides in 2024. This assistance is being provided by the NDRF, subject to a 50% adjustment of the opening balance available in the State Disaster Response Fund (SDRF). The committee also sanctioned Rs 903 crore to Haryana, Madhya Pradesh, and Rajasthan under the National Disaster Response Fund (NDRF) for the expansion and modernisation of fire services. Out of Rs 707.97 crore, Rs 313.69 crore has been approved for Assam and Rs 394.28 crore for Gujarat, the MHA said in a statement. Of the amount allotted for Haryana, Madhya Pradesh, and Rajasthan, Rs 676.33 crore will come as central assistance. The share of the three states is as follows: Rs 117.19 crore for Haryana, Rs 397.54 crore for Madhya Pradesh, and Rs 388.94 crore for Rajasthan. The home minister said the Centre under the prime ministers leadership is standing shoulder to shoulder with the State Governments during natural calamities and disasters and providing all necessary support. It is essential to note that this additional assistance is in addition to the funds already released by the Centre to the States under the State Disaster Response Fund (SDRF), which are already at the disposal of the States. The MHA further added that the Union government has released Rs 13,603.20 crore to 27 states under SDRF and Rs 2,024.04 crore under NDRF to 12 states. Moreover, Rs 4,571.30 crore has been released from the State Disaster Mitigation Fund (SDMF) to 21 states, and Rs 372.09 crore from the National Disaster Mitigation Fund (NDMF) to nine states, the ministry said.
Cough syrup tragedy: Toll hits 17; doctors say toxic chemical affecting brain
Two more children have died from toxic cough syrup Coldrif in Madhya Pradesh, bringing the total to 17 in 43 days. Both victims suffered renal failure and severe brain damage due to diethylene glycol, found at nearly 500% above permissible limits. Officials are conducting a door-to-door survey to retrieve remaining bottles of the banned syrup.
Dr Karan Singh honours Mohsin, Coach Bilquis for Khelo India Gold
Excelsior Sports Correspondent SRINAGAR, Oct 7: Former Sadr-i-Riyasat, Dr. Karan Singh, felicitated young athlete Mohsin Ali and his renowned coach, Paris Olympics Jury Member Bilquis Mir, for winning gold at the recently concluded Khelo India Water Sports event held in Srinagar. The ceremony was also attended by Martand Singh, Trustee of the Hari Tara Charitable Trust and grandson of Dr. Karan Singh. Praising Mohsins exceptional performance against strong rivals from Madhya Pradesh and Punjab, Dr. Singh also lauded Bilquis Mirs [] The post Dr Karan Singh honours Mohsin, Coach Bilquis for Khelo India Gold appeared first on Daily Excelsior .
MP: 20 children died so far due to contaminated cough syrup
Nagpur: Madhya Pradesh Deputy Chief Minister Rajendra Shukla on Tuesday said a total of 20 children from the state have died so far while undergoing treatment for kidney failure after drinking a contaminated cough syrup. He said five children are currently being treated in Nagpur two each in Government Medical College and Hospital (GMCH), Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
Cabinet nod for Rs 24,634 crore multi-tracking Railway projects across four states
NEW DELHI: The Cabinet Committee on Economic Affairs (CCEA), chaired by Prime Minister Narendra Modi on Tuesday approved four major railway multi-tracking projects worth Rs 24,634 crore, spanning nearly 900 km across Maharashtra, Madhya Pradesh, Gujarat, and Chhattisgarh.The projects are expected to be completed by 2030-31 and are designed to ease congestion, boost freight capacity, and enhance connectivity across 18 districts in these states. The decision is seen as major infrastructure push under the PM Gati Shakti National Master Plan, aimed at integrating rail development with multi-modal connectivity and improving logistical efficiency. The government expects the additional rail capacity to bring wide-ranging economic and environmental benefits. Briefing reporters after the cabinet meeting, Railway Minister Ashwini Vaishnaw said that the new projects would significantly enhance Indian Railways' operational efficiency and reliability. The increased line capacity will significantly improve mobility, resulting in improved operational efficiency and service reliability for Indian Railways, he said. The four projects include construction of third and fourth rail lines between Wardha and Bhusawal (314 route km) in Maharashtra, fourth line between Gondia and Dongargarh (84 km), cutting across Maharashtra and Chhattisgarh, two lines between Vadodara and Ratlam (259 km), spanning Gujarat and Madhya Pradesh and one between Itarsi, Bhopal, and Bina (237 km) in Madhya Pradesh. Together, the projects will expand the Indian Railways network by approximately 894 route kilometres and are expected to ease movement along high-density corridors. The rail corridors covered are crucial for both passenger and freight movement and will reduce delays caused by capacity constraints. The Railway Minister said that the four projects will improve connectivity to 3,633 villages with a total population of about 85.84 lakh, including two Aspirational DistrictsVidisha in Madhya Pradesh and Rajnandgaon in Chhattisgarh. These infrastructure upgrades are aligned with the Prime Ministers vision of a self-reliant India (Atmanirbhar Bharat) and are expected to create significant employment and self-employment opportunities in the region, Vaishnaw added. The projects will also facilitate access to key tourism and heritage sites such as Sanchi, Satpura Tiger Reserve, Bhimbetka Rock Shelters, Hazara Falls, and Navegaon National Parkall important destinations that currently face logistical bottlenecks. The newly sanctioned lines are projected to handle additional freight traffic of 78 million tonnes per annum (MTPA), including key commodities like coal, cement, fly ash, steel, food grains, and containers. Vaishnaw also stressed the green benefits of railway expansion over road transport. Indian Railways, being an energy-efficient and environmentally friendly transport system, will help reduce dependence on fossil fuels, he said. The projects are expected to cut Indias oil imports by 28 crore litres and reduce carbon dioxide emissions by 139 crore kilogramsequivalent to planting around six crore trees. The capacity augmentation has been formulated under the PM Gati Shakti framework, which promotes integrated planning across ministries. The aim is to provide seamless movement of goods and people through coordinated infrastructure development. The approval is also seen as one of the most significant recent investments in Indian Railways network expansion strategy which is expected to play a critical role in achieving the countrys broader economic and sustainability goals.
Cough syrup death toll rises to 17 in Madhya Pradesh
Nine children who consumed adulterated Coldrif are under treatment for kidney failure; doctors begin indefinite strike in protest against arrest of paediatrician who prescribed the syrup; they seek action against drug manufacturer and those who approved its use
Kerala bans Sresan Pharmaceuticals' medicines after Tamil Nadu cancels company licence
Kerala has banned medicines from Tamil Nadu's Sresan Pharmaceuticals following the cancellation of its license. The state also halted sales of a Gujarat-made cough syrup, Respifresh TR, found to be substandard. These actions follow recent deaths of children in Madhya Pradesh linked to a 'toxic' cough syrup.
Rail projects will benefit thousands of villages: PM Narendra Modi
The Union Cabinet has approved four major railway projects. These projects will cost over Rs 24,000 crore. They will benefit thousands of villages across Maharashtra, Madhya Pradesh, Gujarat, and Chhattisgarh. Rail connectivity will be strengthened. Congestion will be eased. Logistics efficiency will be enhanced under PM Gati Shakti. Passenger convenience and freight movement will also improve.
Cough syrup deaths: Two more children die in MP's Chhindwara, death toll rises to 16
CHHINDWARA: Two more children undergoing treatment for kidney failure after consuming contaminated cough syrup have died in Madhya Pradesh's Chhindwara, raising the districts death toll to 16, officials said. Today, the death of another girl was reported. So far, 16 children have died in the district, said Chhindwara Additional Collector Dhirendra Singh. Earlier, the state government had confirmed the deaths of 14 children from Chhindwara who had allegedly consumed the cough syrup Coldrif, samples of which were found to have toxic contents. Jayusha Yaduvanshi (2), a resident of Junnardeo in the district, died on Tuesday at a government hospital in Nagpur. Another six children from Chhindwara are undergoing treatment at various hospitals in Nagpur, and the condition of five of them remains critical, the additional collector said. Two-and-half-year-old Dhani Deharia, a resident of Bhariyadhana village in Tamia block, had died on Monday while undergoing treatment at the Nagpur Medical College hospital. Her family members claimed that her health deteriorated after consuming the cold syrup prescribed by the doctor, and her kidneys failed. PIL in Supreme Court seeks CBI probe, national drug safety review over cough syrup deaths A state government official in Bhopal had earlier stated that nine children from Madhya Pradesh were undergoing treatment at various hospitals in Nagpur, seven of them from Chhindwara and two from Betul. Before the deaths of Jayusha Yaduvanshi and Dhani Daharia, the state government had confirmed the deaths of 14 children in Chhindwara. On Monday, the state government suspended two drug inspectors and a deputy director of the Food and Drug Administration (FDA) and transferred the state's drug controller amid an investigation. Chhindwara-based Dr Praveen Soni was arrested for alleged negligence, while a case has been filed against the company that manufactured the Coldrif cough syrup . The Madhya Pradesh Police has formed a Special Investigation Team (SIT) to investigate the deaths and filed a case against the Tamil Nadu-based manufacturer of Coldrif. (With inputs from PTI) Cough syrup deaths: Punjab and HP governments ban Coldrif
Cough syrup deaths: Toll in Madhya Pradesh's Chhindwara rises to 16 as two more kids die
Two more children in Chhindwara, Madhya Pradesh, have died from kidney failure after consuming a contaminated cough syrup, bringing the total to 16. The affected children had reportedly taken the Coldrif syrup, with samples found to contain toxic substances. Investigations are ongoing, leading to suspensions and arrests.
Cough Syrup Deaths Rise In Madhya Pradesh, Opposition Makes 'Bulldozer' Demand
What began as a mystery illness among children in Madhya Pradesh's Chhindwara district has now turned into a full-blown public health scandal and also sparked a political slugfest.
The alarming incident occurred against the backdrop of intense controversy surrounding CJIs remarks on September 16, during a Supreme Court hearing concerning the restoration of a Lord Vishnu idol at the Khajuraho Temple complex in Madhya Pradesh
Cabinet approves four rail multitracking projects worth Rs 24,634 crore
The Cabinet Committee on Economic Affairs has approved four multitracking railway projects worth Rs 24,634 crore across Maharashtra, Madhya Pradesh, Gujarat, and Chhattisgarh. These projects will add 894 route kilometres to the network, enabling an additional 78 million tonnes of freight annually and enhancing connectivity to key destinations.
Bright Idea, Dark Reality: Madhya Pradesh Anganwadis Get LED TVs, But No Electricity
In Madhya Pradesh's Umaria district, officials distributed shiny new LED TVs and water filters to 116 Anganwadi centres as part of the 'Saksham Anganwadi' modernisation drive. The catch? Not one of these centres has an electricity connection.
13,000, Including PhDs, Compete for 1 Constable Post In Madhya Pradesh
The khaki uniform has widely been considered a symbol of pride. But in Madhya Pradesh, it has now become a symbol of survival. After years of waiting, the recruitment for police constables has finally been announced, drawing a huge response.
Congress demands judicial probe, compensation for deceased`s families
The opposition party also accused the governments in Madhya Pradesh and Rajasthan of giving a clean chit to the companies that had manufactured the cough syrup that was allegedly responsible for the deaths of the children
Punjab Bans Coldrif Cough Syrup After Child Deaths in Madhya Pradesh
Chandigarh, Oct 7: The Punjab government has issued an immediate ban on the sale, distribution, and use of Coldrif cough syrup following the deaths of 14 children in Madhya Pradesh, allegedly linked to the contaminated medicine. An order from the Food and Drugs Administration (FDA), Punjab, stated that the drug, batch number SR-13, manufactured by [] The post Punjab Bans Coldrif Cough Syrup After Child Deaths in Madhya Pradesh appeared first on Northlines .
NEW DELHI, Oct 7: A high-level committee headed by Union Home Minister Amit Shah has approved Rs 707.97 crore of additional central assistance for Assam and Gujarat that were hit by floods and landslides in 2024. The committee has also approved Rs 903.67 crore for Haryana, Madhya Pradesh and Rajasthan from the National Disaster Response Fund (NDRF) for the expansion and modernisation of the state fire services. A high-level committee, headed by the Union home minister, has approved Rs 707.97 [] The post Centre approves Rs 707 Cr for Assam, Gujarat for floods; Rs 903 Cr for Haryana, MP, Rajasthan for fire services appeared first on Daily Excelsior .
Gujarat government cracks down on two pharmaceutical companies amid cough syrup scare
The Gujarat government has cracked down on two pharmaceutical companies after multiple cough syrup samples manufactured in the state were found to be Not of Standard Quality (NSQ). 16 children died from kidney failure in Chhindwara, Madhya Pradesh, allegedly linked to toxic cough syrups. Alarming reports from Madhya Pradesh and Rajasthan raised concerns about drug safety and regulatory vigilance. Investigations by the Gujarat Food and Drug Department revealed that two Gujarat-made syrups, Re-Life and Respifresh TR, are Not of Standard Quality. Both syrups were manufactured in Gujarat Re-Life by M/s Shape Pharma Pvt. Ltd. in Surendranagars Muli taluka, and Respifresh TR by M/s Rednex Pharmaceuticals Pvt. Ltd. in Ahmedabads Bavla taluka. Health Minister Hrishikesh Patel confirmed the sweeping action, stating, The Gujarat government will ensure that not a single unsafe bottle remains in circulation. FDCA officials have been directed to monitor the process till the last bottle is withdrawn. The Food and Drug Control Authority (FDCA) has imposed a blanket ban on the sale, supply, and distribution of both syrups. Distributors, wholesalers, and retailers are now under strict watch, with Assistant Commissioners tasked to oversee the recall and submit daily progress reports to the Joint Commissioner (Drugs). To prevent further risk, the government has also ordered a comprehensive probe into all cough syrup producers in Gujarat. There are currently 624 licensed oral liquid manufacturers operating across the state, many of whom supply products both domestically and nationally. Between October 3 and 5, the FDCA, in collaboration with the Central Drugs Standard Control Organization (CDSCO), conducted risk-based joint inspections of Shape Pharma and Rednex Pharmaceuticals. During the operation, 14 additional syrup samples, three from Shape and eleven from Rednex, were seized and sent to government laboratories for detailed chemical analysis. Action will follow once test results are confirmed. Minister Patel stressed that the states priority is public health and patient safety, asserting that the FDCA has issued strict instructions to all district drug commissioners to conduct intense inspections of every oral liquid and cough syrup unit in their jurisdiction. He added, The Gujarat government will leave no loophole when it comes to the safety, quality, and efficacy of medicines. Every firm in violation will face decisive action.
MP govt to bear treatment costs for children affected by contaminated cough syrup
Madhya Pradesh government will cover all treatment costs for children suffering kidney infections from contaminated cough syrup. Fourteen children have died in Chhindwara due to suspected renal failure linked to the oxic Coldrif syrup. Authorities have suspended drug inspectors and arrested a doctor amid an ongoing investigation.
Coldrif cough syrup deaths: MP govt to bear treatment costs
Bhopal: The Madhya Pradesh government will bear the entire cost of treatment of children suffering from kidney infections after taking a contaminated cough syrup in Chhindwara and Betul districts, an official said on Tuesday. Fourteen children from Chhindwara have died due to suspected renal failure, linked to the consumption of the toxic Coldrif cough syrup, Get the latest updates in Hyderabad City News , Technology , Entertainment , Sports , Politics and Top Stories on WhatsApp & Telegram by subscribing to our channels. You can also download our app for Android and iOS .
Death toll rises to 13 in MP as another toddler succumbs to death
A 1.5-year-old from Madhya Pradesh, died due to acute renal failure caused by contaminated Coldrif cough syrup. This tragedy marks the 13th confirmed child fatality, prompting investigations, drug bans, and government measures to provide ex gratia and medical support to affected families
NEW DELHI: The Congress on Tuesday alleged that the government's import policy for yellow peas has eaped substantial profits for the Adani Group with farmers suffering huge losses. Congress general secretary in-charge communications Jairam Ramesh said this was yet another clear example of how the so-called 'Atmanirbhar Bharat' has been reduced to 'Modani-nirbhar Bharat'. He said that in 2014-25, India imported over 67 lakh tonnes of pulses, of which approximately 30 lakh tonnes were yellow peas, which is considered a substitute to pulses. Ramesh pointed out that due to the absence of import duty on yellow peas, imported peas are reaching the market at a significantly lower price compared to domestic pulses. The price of imported peas is Rs 3,500 per quintal, which is roughly half the MSP of Rs 7,000-8,000 per quintal for domestic pulses. As a result, cheap imports have flooded the market, making it impossible for domestic pulses to compete, rendering them unprofitable for farmers in Maharashtra, Madhya Pradesh, Rajasthan, Gujarat, and Uttar Pradesh, he said in a post on X. ! 2024-25 67 , 30 , Jairam Ramesh (@Jairam_Ramesh) October 7, 2025 While farmers are suffering huge losses, the largest importer of yellow peas the Adani Group has reaped substantial profits, Ramesh claimed. There was no immediate reaction from the government or the Adani Group on the Congress' claims. To curb high food inflation, the 50 per cent basic customs duty on yellow peas was emporarily removed in December 2023; however, despite repeated appeals from farmers, the government has continued with this decision, Ramesh said. Even institutions like the Commission for Agricultural Costs and Prices (CACP), NITI Aayog, and the Supreme Court have advised imposing restrictions on unrestricted imports to protect farmers. Yet, the central government ignored these warnings and continued the customs duty exemption on yellow peas, he said, adding that now, this exemption has been extended until March 2026. This is yet another clear example of how the so-called 'Atmanirbhar Bharat' has, in reality, become a 'Modani-Nirbhar Bharat, Ramesh said. Modani ki peeli daal mein kuch toh kaala hai, he said in his post in Hindi, taking a dig at the Adani Group and the central government.
Cabinet gives nod to 4 major railway projects worth Rs 24,634 cr
The Union Cabinet on Tuesday approved four major railway projects worth 24,634 crore to boost capacity and connectivity across central India. The projects include third and fourth lines along the WardhaBhusawal (314 km), GondiaDongargarh (84 km), VadodaraRatlam (259 km), and ItarsiBhopalBina (237 km) routes, spanning 18 districts across Maharashtra, Madhya Pradesh, Gujarat, and Chhattisgarh.
